Lubna Naaz Chaudhary (Lubna N Chaudhary)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Locally Advanced

Endoplasmic Reticulum

Top Venues

Journal of personalized medicine

Exploration of targeted anti-tumor therapy

JCO oncology practice

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Julie M Jorns, Yunguang Sun, Sailaja Kamaraju, Yee Chung Cheng, Amanda Kong, Tina W F Yen, Caitlin R Patten, Chandler S Cortina, Christopher R Chitambar, Hallgeir Rui, Lubna Naaz Chaudhary
Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer. Journal of personalized medicine 14 (5) (2024)
Julie M Jorns, Yunguang Sun, Sailaja Kamaraju, Yee Chung Cheng, Amanda Kong, Tina W F Yen, Caitlin R Patten, Chandler S Cortina, Christopher R Chitambar, Hallgeir Rui, Lubna Naaz Chaudhary
Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer. Journal of personalized medicine 14 (5) (2024)
Lubna Naaz Chaudhary, Julie M Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind, Mary Beth Gonyo, Amanda L Kong, Caitlin Patten, Tina Yen, Chandler S Cortina, Ebony Carson, Nedra Johnson, Carmen Bergom, Shirng-Wern Tsaih, Anjishnu Banerjee, Yu Wang, Inna Chervoneva, Elizabeth Weil, Christopher R Chitambar, Hallgeir Rui
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy. Breast cancer research and treatment (2023)
Sabah Alaklabi, Arya Mariam Roy, Lubna Naaz Chaudhary, Shipra Gandhi
Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? Exploration of targeted anti-tumor therapy 4 (6) (2023)
Lubna Naaz Chaudhary, Julie Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind, MaryBeth Gonyo, Amanda Kong, Caitlin Patten, Tina Yen, Chandler Cortina, Ebony Carson, Nedra Johnson, Carmen Bergom, Shirng-Wern Tsaih, Anjishnu Banerjee, Yu Wang, Inna Chervoneva, Elizabeth Weil, Christopher R Chitambar, Hallgeir Rui
Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy. Research square (2023)
Sabah Alaklabi, Arya Mariam Roy, Lubna Naaz Chaudhary, Shipra Gandhi
Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? Exploration of targeted anti-tumor therapy 4 (6) (2023)
Lubna Naaz Chaudhary
Clinical and Psychosocial Challenges of Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years. JCO oncology practice 17 (6) (2021)